| Bid Price | 19.00p | High Price | 20.50p |
|---|
| Ask Price | 19.50p | Low Price | 16.50p |
|---|
| Open Price | 17.00p | Spread | 2.56% |
|---|
| Prev Close | 17.00p | Volume | 2,830,723 |
|---|
Creo Medical Group PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Dec 20, 2024 | 17.00 | 20.50 | 16.50 | 19.25 | 2,830,723 |
| Dec 19, 2024 | 16.25 | 17.48 | 16.00 | 17.00 | 455,044 |
| Dec 18, 2024 | 17.25 | 17.50 | 16.00 | 16.25 | 1,045,559 |
| Dec 17, 2024 | 17.50 | 18.00 | 17.00 | 17.25 | 882,875 |
| Dec 16, 2024 | 17.13 | 18.00 | 17.00 | 17.50 | 798,621 |
Creo Medical Group PLC Information
| Name | Creo Medical Group PLC | Index | FTSE AIM All Share |
|---|
| ISIN | GB00BZ1BLL44 | Epic | CREO |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | ASQ1 |
|---|
| Industry | Medical Devices | Sector | Healthcare |
|---|
| EMS | 10,000 | Trading Status | Closed |
|---|
| Shares in Issue | 412.15 m | Prev Close | 17.00p |
|---|
| PE Ratio | | Market Cap | £79.34 m |
|---|
| Div Yield | 0 | Div per Share | £NaN |
|---|
| EPS | -£0.03 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | -0.188294 | DPS Growth (%) | 0 |
|---|
| Current Ratio | 3.242424 | Quick Ratio | 1.989899 |
|---|
Creo Medical Group PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 16/12/24 | BUY | Kevin Crofton | CH | 1,179,000 @ £0.17 | £200,607.00 |
| 24/10/24 | BUY | Richard Rees | FD | 76,740 @ £0.20 | £15,360.00 |
| 24/10/24 | SELL | Richard Rees | FD | 174,740 @ £0.20 | £34,948.00 |
| 24/10/24 | BUY | Richard Rees | FD | 98,000 @ £0.20 | £19,615.00 |
| 21/10/24 | PLAC | Richard Rees | FD | 208,333 @ £0.24 | £50,000.00 |
| 21/10/24 | BUY | Richard Rees | FD | 208,333 @ £0.24 | £50,000.00 |
| 21/10/24 | PLAC | Kevin Crofton | CH | 2,916,666 @ £0.24 | £700,000.00 |
| 21/10/24 | BUY | Kevin Crofton | CH | 2,916,666 @ £0.24 | £700,000.00 |
| 06/08/24 | TIN | Craig Gulliford | CEO | 5,496 @ £0.00 | £0.00 |
| 06/08/24 | BUY | Craig Gulliford | CEO | 2,748 @ £0.33 | £900.00 |
Creo Medical Group PLC News
